Pfizer picks up Brazil's Teuto in $240M deal

Pfizer will pay $240 million for a 40 percent stake in Brazil's Laboratorio Teuto Brasileiro, a generics specialist, as it expands further in emerging markets. Report

Suggested Articles

Amarin Vascepa pill
Pharma

Amarin eyes blockbuster Vascepa sales with FDA label boost

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

by Kyle Blankenship
courthouse
Pharma

Gilead's Kite Pharma told to pay $752M for CAR-T infringement

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

by Eric Sagonowsky
Pfizer
Marketing

Pfizer's Xeljanz gets convenience boost with new XR formula

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.

by Carly Helfand